Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?

被引:9
|
作者
Zaveri, Mitul P. [1 ]
Perry, Jamal C. [2 ]
Schuetz, Tayna M. [2 ]
Memon, Mohammad D. [2 ]
Faiz, Sadaf [2 ]
Cancarevic, Ivan [1 ]
机构
[1] Calif Inst Behav Neurosci & Psychol, Internal Med, Fairfield, CA 94534 USA
[2] Calif Inst Behav Neurosci & Psychol, Med, Fairfield, CA USA
关键词
dilated cardiomyopthy; type 2 diabetes mellitus; diabetic cardiomyopathy; DILATED CARDIOMYOPATHY; OLMSTED COUNTY; HEART-FAILURE;
D O I
10.7759/cureus.11100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dilated cardiomyopathy (DCM) is a common form of cardiomyopathy that affects the cardiac muscle. It is a life-threatening condition that causes heart failure as it decreases the myocardial ability to pump sufficient blood throughout the body. Numerous causes trigger DCM without pathophysiology; however, the key concept is a decrease in the systolic function of either the left ventricle or of both the left and right ventricles. Long-term diabetes plays an important role in the pathogenesis of DCM in the form of diabetic cardiomyopathy. Diabetic cardiomyopathy is a non-ischemic form of DCM, which is associated with diabetes. It is unrelated to atherosclerosis and hypertension. The PubMed and Google Scholar databases were used to identify the relevant studies related to diabetes and DCM. We found that diabetes was associated with cardiac muscle injury by activating the renin-angiotensin-aldosterone system, myocardial inflammation, and fibrosis. Based on the available data, we concluded that there is strong evidence to support the interrelation of DCM and diabetes.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
    Jia, Guanghong
    Hill, Michael A.
    Sowers, James R.
    [J]. CIRCULATION RESEARCH, 2018, 122 (04) : 624 - 638
  • [2] Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
    Mizamtsidi, Maria
    Paschou, Stavroula A.
    Grapsa, Julia
    Vryonidou, Andromachi
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (11) : 947 - 953
  • [3] Diabetic cardiomyopathy: a controversial entity
    Karamitsos, Theodoros D.
    Tsapas, Apostolos
    Arnold, Jayanth R.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (04) : 564 - 564
  • [4] Is diabetic cardiomyopathy a specific entity?
    Letonja, Mitja
    Petrovic, Danijel
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (01): : 8 - 13
  • [5] Is Diabetic Cardiomyopathy a specific entity?
    Bounhoure, Jean-Paul
    Komajda, Michel
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2017, 201 (1-3): : 325 - 337
  • [6] Diabetic cardiomyopathy: Myth or reality?
    Ernande, Laura
    Derumeaux, Genevieve
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2012, 105 (04) : 218 - 225
  • [7] Diabetic cardiomyopathy: a controversial entity: reply
    Konduracka, Ewa
    Gackowski, Andrzej
    Rostoff, Pawel
    Galicka-Latala, Danuta
    Frasik, Wieslaw
    Piwowarska, Wieslawa
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (04) : 565 - 565
  • [8] Diabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence?
    Schilling J.D.
    Mann D.L.
    [J]. Current Cardiovascular Risk Reports, 2014, 8 (12) : 1 - 9
  • [9] Phantom organ pain: a myth or a clinical entity
    Roldan, C.
    Nguyen, D.
    [J]. JOURNAL OF PAIN, 2013, 14 (04): : S8 - S8
  • [10] Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes
    Stanton, Ana Maria
    Vaduganathan, Muthiah
    Chang, Lee-Shing
    Turchin, Alexander
    Januzzi, James L., Jr.
    Aroda, Vanita R.
    [J]. CURRENT DIABETES REPORTS, 2021, 21 (10)